No guidance ?? The addressable market looks pretty massive to me and now with CE mark , RHT will be re rated worth in the $billions!
With an estimated global prevalence of between 24-30%1 , NAFLD affects up to 2.3 billion people, a figure expected to grow year-on-year. Of these, about 470 million people (or 20%) will develop NASH2 .
Ann: HepaFat-AI Receives TGA Approval, page-45
Add RHT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $35.75M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 81906 | 7.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.2¢ | 11904 | 1 |
View Market Depth
| Last trade - 16.12pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
8.3¢ |
Change
0.000 ( 5.06 %) |
||||
| Open | High | Low | Volume | ||
| 8.3¢ | 8.3¢ | 8.3¢ | 1152 | ||
| Last updated 11.39am 06/05/2024 ? | |||||
| RHT (ASX) Chart |
Day chart unavailable